Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients.

Clinical trial NCT06590740 · COMPLETED

Trial details

NCT number: NCT06590740
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cough-Variant Asthma

Start date: 2024-10-18
Primary completion: 2025-09-03
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.